Vitamin D: Link between osteoporosis, obesity, and diabetes?

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6569-6591

  Cândido, Flávia Galvão ^a   Bressan, Josefina ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Bone mineral density; Diabetes mellitus; Falls; Fractures; Obesity; Osteoblasts; Osteoclasts; Osteoporosis; PTH; Vitamin D

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ADIPOGENESIS; ADIPOSE TISSUE; BONE DENSITY; CONTROLLED STUDY; FALL RISK; FOLLOW UP; HUMAN; INFORMATION RETRIEVAL; MINERALIZATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUN EXPOSURE; VITAMIN SUPPLEMENTATION; CHEMISTRY; METABOLISM; PATHOLOGY;

BONE DENSITY; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; OSTEOPOROSIS; VITAMIN D;

EID: 84899146419     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046569     Document Type: Review

References (107)

1. Lips, P.; Schoor, N.M.V. The effect of vitamin D on bone and osteoporosis. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25, 585-591.
2. Rosen, C.J.; Adams, J.S.; Bikle, D.D.; Black, D.M.; Demay, M.B.; Manson, J.E.M.; Murad, H.; Kovacs, C.S. The nonskeletal effects of vitamin D: An endocrine society scientific statement. Endocr. Rev. 2012, 33, 456-492.
3. Gomez-Ambrosi, J.; Rodriguez, A.; Catalan, V.; Fruhbeck, G. The bone-adipose axis in obesity and weight loss. Obes. Surg. 2008, 18, 1134-1143.
4. Migliaccio, S.; Greco, E.A.; Fornari, R.; Donini, L.M.; Lenzi, A. Is obesity in women protective against osteoporosis? Diabetes Metab. Syndr. Obes. 2011, 4, 273-282.
5. Ross, A.C.; Abrams, S.A.; Aloia, J.F.; Brannon, P.M.; Clinton, S.K.; Durazo-Arvizu, R.A.; Gallagher, J.C.; Gallo, R.L.; Jones, G.; Kovacs, C.S. et al. Institute of medicine (US) committee to review dietary reference intakes for vitamin D and calcium. In Dietary Reference Intakes for Calcium and Vitamin D; Ross, A.C., Taylor, C.L., Yaktine, A.L., Valle, H.B.D., Eds.; National Academies Press (US): Washington, DC, USA, 2011.
6. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Evaluation, treatment, prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011, 96, 1911-1930.
7. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 2012, 97, 1153-1158.
8. Haussler, M.R.; Whitfield, G.K.; Kaneko, I.; Haussler, C.A.; Hsieh, D.; Hsieh, J.C.; Jurutka, P.W. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 2013, 92, 77-98.
9. Ashwell, M.; Stone, E.M.; Stolte, H.; Cashman, K.D.; Macdonald, H.; Lanham-New, S.; Hiom, S.; Webb, A.; Frase, D. UK food standards agency workshop report: An investigation of the relative contributions of diet and sunlight to vitamin D status. Br. J. Nutr. 2010, 104, 603-611.
10. Tsiaras, W.G.; Weinstoc, M.A. Factors influencing vitamin D status. Acta Derm. Venereol. 2011, 91, 115-124.
11. Bens, G. Sunscreens. Adv. Exp. Med. Biol. 2008, 624, 137-161.
12. Blum, M.; Dolnikowski, G.; Seyoum, E.; Harris, S.S.; Booth, S.L.; Peterson, J.; Saltzman, E.; Dawson-Hughes, B. Vitamin D(3) in fat tissue. Endocrine 2008, 33, 90-94.
13. Hanley, D.A.; Cranney, A.; Jones, G.; Whiting, S.J.; Leslie, W.D.; Cole, D.E.C.; Atkinson, S.A.; Josse, R.G.; Feldman, S.; Kline, G.A. et al. Vitamin D in adult health and disease: A review and guideline statement from Osteoporosis Canada. Can. Med. Assoc. J. 2010, 182, 610-618.
14. Holick, M.F. The role of vitamin D for bone health and fracture prevention. Curr. Osteoporos. Rep. 2006, 4, 96-102.
15. Souberbielle, J.C.; Body, J.J.; Lappe, J.M.; Plebani, M.; Shoenfeld, Y.; Wang, T.J.; Bischoff-Ferrari, H.A.; Cavalier, E.; Ebeling, P.R.; Fardellone, P. et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun. Rev. 2010, 9, 709-715.
16. Bischoff-Ferrari, H.A.; Shao, A. Dawson-Hughes, B.; Hathcock, J.; Giovannucci, E.; Willett, W.C. Benefit-Risk assessment of vitamin D supplementation. Osteoporos. Int. 2010, 21, 1121-1132.
17. Cunningham, J.; Locatelli, F.; Rodriguez, M. Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options. Clin. J. Am. Soc. Nephrol. 2011, 6, 913-921.
18. Lamprecht, A.S.; Lipkin, M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat. Rev. Cancer 2003, 3, 601-614.
19. Peacock, M. Calcium metabolism in health and disease. Clin. J. Am. Soc. Nephrol. 2010, 5, 23-30.
20. Lips, P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006, 92, 4-8.
21. Yasuda, H.; Higashio, K.; Suda, T. Vitamin D and osteoclastogenesis. In Vitamin D; Feldman, D. Pike, J. W. Glorieux, F. H., Eds.; Elsevier Academic Press: San Diego, CA, USA, 2005; Volume 2, pp. 665-685.
22. Lisse, T.S.; Chun, R.F.; Rieger, S.; Adams, J.S.; Hewison, M. Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts. J. Bone Miner. Res. 2013, 28, 1478-1488.
23. Kogawa, M.; Anderson, P.H.; Findlaya, D.M.; Morris, H.A.; Atkins, G.J. The metabolism of 25-(OH) vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J. Steroid Biochem. Mol. Biol. 2010, 121, 277-280.
24. Diamond, T.; Wong, Y.K.; Golombick, T. Effect of oral cholecalciferol 2000 vs. 5000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency. Osteoporos. Int. 2013, 24, 1101-1105.
25. Martin, T.J.; Sims, N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 2005, 11, 76-81.
26. Zhu, K.; Devine, A.; Dick, I.M.; Wilson, S.G.; Prince, R.L. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: A five-year randomized controlled trial. J. Clin. Endocrinol. Metab. 2008, 93, 743-749.
27. Bischoff-Ferrari, H.A.; Dietrich, T.; Orav, E. J. Dawson-Hughes, B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: A population-based study of younger and older adults. Am. J. Med. 2004, 116, 634-639.
28. Kuchuk, N.O.; Pluijm, S.M.; van Schoor, N.M.; Looman, C.W.; Smit, J.H.; Lips, P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J. Clin. Endocrinol. Metable 2009, 94, 1244-1250.
29. Kuchuk, N.O.; van Schoor, N.M.; Pluijm, S.M.; Chines, A.; Lips, P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: Global perspective. J. Bone Miner. Res. 2009, 24, 693-701.
30. Van Schoor, N.M.; Visser, M.; Pluijm, S.M.; Kuchuk, N.; Smit, J.H.; Lips, P. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone 2008, 42, 260-266.
31. Larrosa, M.; Gomez, A.; Casado, E.; Moreno, M.; Vázquez, I.; Orellana, C.; Berlanga, E.; Ramon, J.; Gratacos, J. Hypovitaminosis D as a risk factor of hip fracture severity. Osteoporos. Int. 2012, 23, 607-661.
32. Holick, M.F.; Siris, E.S.; Binkley, N.; Beard, M.K.; Khan, A.; Katzer, J.T.; Petruschke, R.A.; Chen, E.; de Papp, A.E. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. 2005, 8, 3215-3224.
33. Harwood, R.H.; Sahota, O.; Gaynor, K.; Masud, T.; Hosking, D.J. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) study. Age Ageing 2004, 33, 45-51.
34. Jackson, R.D.; LaCroix, A.Z.; Gass, M.; Wallace, R.B.; Robbins, J.; Lewis, C.E.; Bassford, T.; Beresford, S.A.A.; Black, H.R.; Blanchette, P. et al. Calcium plus vitamin D supplementation and the risk of fractures. N. Engl. J. Med. 2006, 354, 669-683.
35. Karkkainen, M.; Tuppurainen, M.; Salovaara, K.; Sandini, L.; Rikkonen, T.; Sirola, J.; Honkanen, R.; Jurvelin, J.; Alhava, E.; Kröger, H. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: A 3-year randomized population-based trial (OSTPRE-FPS). Osteoporos. Int. 2010, 21, 2047-2055.
36. Moschonis, G.; Katsaroli, I.; Lyritis, G.P.; Manios, Y. The effects of a 30-month dietary intervention on bone mineral density: The postmenopausal health study. Br. J. Nutr. 2010, 104, 100-107.
37. Jorde, R.; Sneve, M.; Torjesen, P.A.; Figenschau, Y.; Hansen, J-B.; Grimnes, G. No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year. Nutr. J. 2010, 9, 1, doi:10.1186/1475-2891-9-1.
38. Islam, M.Z.; Shamim, A.; Viljakainen, H.T.; Akhtaruzzaman, M.; Jehan, A.H.; Khan, H.U.; Al-Arif, F.A.; Lamberg-Allardt, C. Effect of vitamin D, calcium and multiple micronutrient supplementation on vitamin D and bone status in Bangladeshi premenopausal garment factory workers with hypovitaminosis D: A double-blinded, randomised, placebo-controlled 1-year intervention. Br. J. Nutr. 2010, 104, 241-247.
39. Rastelli, A.L.; Taylor, M.E.; Gao, F.; Armamento-Villareal, R.; Jamalabadi-Majidi, S.; Napoli, N.; Ellis, M.J. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): A phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res. Treat. 2011, 129, 107-116.
40. Steffensen, L.H.; Jorgensen, L.; Straume, B.; Mellgren, S.I.; Kampman, M.T. Can vitamin D(3) supplementation prevent bone loss in persons with MS? A placebo-controlled trial. J. Neurol. 2011, 258, 1624-1631.
41. Verschueren, S.M.P.; Bogaerts, A.; Delecluse, C.; Claessens, A.L.; Haentjens, P.; Vanderschueren, D.; Boonen, S. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: A 6-month randomized, controlled trial. J. Bone Miner. Res. 2011, 26, 42-49.
42. Grimnes, G.; Joakimsen, R.; Figenschau, Y.; Torjesen, P.A.; Almas, B.; Jorde, R. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass-a randomized controlled 1-year trial. Osteoporos. Int. 2012, 23, 201-211.
43. Nieves, J.; Cosman, F.; Grubert, E.; Ambrose, B.; Ralston, S.; Lindsay, R. Skeletal effects of vitamin D supplementation in postmenopausal black women. Calcif. Tissue Int. 2012, 91, 316-324.
44. Macdonald, H.M.; Wood, A.D.; Aucott, L.S.; Black, A.J.; Fraser, W.D.; Mavroeidi, A.; Reid, D.M.; Secombes, K.R.; Simpson, W.G.; Thies, F. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: A 1 year double-blind RCT in postmenopausal women. J. Bone Miner. Res. 2013, 28, 2202-2213.
45. Wamberg, L.; Pedersen, S.B.; Richelsen, B.; Rejnmark, L. The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin D: Results from a randomized controlled study. Calcif. Tissue Int. 2013, 93, 69-77.
46. Lenchik, L.; Kiebzak, G.M.; Blunt, B.A. What is the role of serial bone mineral density measurements in patient management? J. Clin. Densitom. 2002, 5, 29-38.
47. Trivedi, D. Doll, R. Khaw, K. Effect of four monthly oral vitamin D supplementation on fractures and mortality in men and women living in the community: Randomized double blind controlled trial. BMJ 2003, 326, 469-475.
48. Larsen, E. R. Mosekilde, L. Foldspang, A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: A pragmatic population-based 3-year intervention study. J. Bone Miner. Res. 2004, 19, 370-378.
49. Grant, A.M.; Avenell, A.; Campbell, M.K.; McDonald, A.M.; MacLennan, G.S.; McPherson, G.C.; Anderson, F.H.; Cooper, C.; Francis, R.M.; Donaldson, C. et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised evaluation of Calcium or vitamin D, RECORD): A randomised placebo-controlled trial. Lancet 2005, 365, 1621-1628.
50. Porthouse, J.; Cockayne, S.; King, C.; Saxon, L.; Steele, E.; Aspray, T.; Baverstock, M.; Birks, Y.; Dumville, J.; Francis, R. et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005, 330, 1003.
51. Flicker, L.; MacInnis, R.J.; Stein, M.S.; Scherer, S.C.; Mead, K.E.; Nowson, C.A.; Thomas, J.; Lowndes, C.; Hopper, J.L.; Wark, J.D. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J. Am. Geriatr. Soc. 2005, 53, 1881-1888.
52. Lyons, R.A.; Johansen, A.; Brophy, S.; Newcombe, R.G.; Phillips, C.J.; Lervy, B.; Evans, R.; Wareham, K.; Stone, M.D. Preventing fractures among older people living in institutional care: A pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos. Int. 2007, 18, 811-818.
53. Smith, H.; Anderson, F.; Raphael, H.; Maslin, P.; Crozier, S.; Cooper, C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women: a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007, 46, 1852-1857.
54. Pfeifer, M. Begerow, B. Minne, H. W. Suppan, K. Fahrleitner-Pammer, A. Dobnig, H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos. Int. 2009, 20, 315-322.
55. Sanders, K.M.; Stuart, A.L.; Williamson, E.J.; Simpson, J.A.; Kotowicz, M.A.; Young, D.; Nicholson, G.C. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 2010, 303, 1815-1822.
56. Salovaara, K.; Tuppurainen, M.; Karkkainen, M.; Rikkonen, T.; Sandini, L.; Sirola, J.; Honkanen, R.; Alhava, E.; Kröger, H. Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: A population-based 3-year randomized, controlled trial: The OSTPRE-FPS. J. Bone Miner. Res. 2010, 25, 1487-1495.
57. Bakhtiyarova, S.; Lesnyak, O.; Kyznesova, N.; Blankenstein, M.A.; Lips, P. Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos. Int. 2006, 17, 441-446.
58. Bischoff-Ferrari, H.A.; Willett, W.C.; Orav, E.J.; Lips, P.; Meunier, P.J.; Flicker, L.; Wark, J.; Jackson, R.D.; Cauley, J.A.; Meyer, H. E. et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N. Engl. J. Med. 2012, 367, 40-49.
59. Lamendola, C.A.; Ariel, D.; Feldman, D.; Reaven, G.M.;Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am. J. Clin. Nutr. 2012, 95, 1055-1059.
60. Norman, A.W. Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology 2006, 147, 5542-5548.
61. Wang, Y.; Zhu, J.; DeLuca, H.F. Where is the vitamin D receptor? Arch. Biochem. Biophys. 2012, 523, 123-133.
62. Bland, R.; Markovic, D.; Hills, C.E.; Hughes, S.V.; Chan, S.L.; Squires, P.E.; Hewison, M. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J. Steroid Biochem. Mol. Biol. 2004, 89, 121-125.
63. Ding, C.; Gao, D.; Wilding, J.; Trayhurn, P.; Bing, C. Vitamin D signalling in adipose tissue. Br. J. Nutr. 2012, 108, 1915-192.
64. Maestro, B.; Davila, N.; Carranza, M.C.; Calle, C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J. Steroid Biochem. Mol. Biol. 2003, 84, 223-230.
65. Wolden-Kirk, H.; Overbergh, L.; Christesen, H.T.; Brusgaard, K.; Mathieu, C. Vitamin D and diabetes: Its importance for beta cell and immune function. Mol. Cell. Endocrinol. 2011, 347, 106-120.
66. Alvarez, J.A.; Ashraf, A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int. J. Endocrinol. 2010, doi:10.1155/2010/351385.
67. Soares, M.J.; Murhadi, L.L.; Kurpad, A.V.; Chan She Ping-Delfos, W. L.; Piers, L. S. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes. Rev. 2012, 13, 592-605.
68. De Paula, F.J.; Dick-de-Paula, I.; Bornstein, S.; Rostama, B.; Le, P.; Lotinun, S.; Baron, R.; Rosen, C.J. VDR haploinsufficiency impacts body composition and skeletal acquisition in a gender specific manner. Calcif. Tissue Int. 2011, 89, 179-191.
69. Maestro, B.; Molero, S.; Bajo, S.; Dávila, N.; Calle, C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D 3. Cell Biochem. Funct. 2002, 20, 227-232.
70. Dunlop, T.W.; Väisänen, S.; Frank, C.; Molnár, F.; Sinkkonen, L.; Carlberg, C.; Karn, J. The human peroxisome proliferator-activated receptor δ gene is a primary target of 1α, 25-dihydroxyvitamin D3 and its nuclear receptor. J. Mol. Biol. 2005, 349, 248-260.
71. Maestro, B.; Campion, J.; Davila, N.; Calle, C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 2000, 47, 383-391.
72. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
73. Vimaleswaran, K.S.; Berry, D.J.; Lu, C.; Tikkanen, E.; Pilz, S.; Hiraki, L.T.; Cooper, J.D.; Dastani, Z.; Li, R.; Houston, D. K. et al. Causal relationship between obesity and vitamin D status: Bi-directional mendelian randomization analysis of multiple cohorts. PLoS Med. 2013, 10, 1-13.
74. Lee, N.K.; Sowa, H.; Hinoi, E.; Ferron, M.; Ahn, J.D.; Confavreux, C.; Dacquin, R.; Mee, P.J.; McKee, M.D.; Jung, D. Y. et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130, 456-469.
75. Gómez-Ambrosi, J.; Catalán, V.; Ramírez, B.; Rodríguez, A.; Colina, I.; Silva, C.; Rotellar, F.; Mugueta, C.; Gil, M.J.; Cienfuegos, J.A. et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metab. 2007, 92, 3719-3727.
76. Nomiyama, T.; Perez-Tilve, D.; Ogawa, D.; Gizard, F.; Zhao, Y.; Heywood, E.B.; Jones, K.L.; Kawamori, R.; Cassis, L.A.; Tschöp, M. H. et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J. Clin. Investig. 2007, 117, 2877-2888.
77. Fukumoto, S.; Martin, T.J. Bone as an endocrine organ. Trends Endocrin. Met. 2009, 20, 230-236.
78. Almerighi, C.; Sinistro, A.; Cavazza, A.; Ciaprini, C.; Rocchi, G.; Bergamini, A. 1α,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009, 45, 190-197.
79. Eftekharian, M.M.; Zarnani, A.H.; Moazzeni, S. M. In vivo effects of calcitriol on phenotypic and functional properties of dendritic cells. Iran J. Immunol. 2010, 7, 74-82.
80. Jeffery, L.E.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O.S.; Hewison, M.; Walker, L.S.; Lammas, D.A.; Raza, K.; Sansom, D.M. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP 3. J. Immunol. 2009, 183, 5458-5467.
81. Chen, S.; Sims, G.P.; Chen, X.X.; Gu, Y.Y.; Chen, S.; Lipsky, P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179, 1634-1647.
82. Baeke, F.; Takiishi, T.; Korf, H.; Gysemans, C.; Mathieu, C. Vitamin D: Modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10, 482-496.
83. Ducloux, R.; Nobécourt, E.; Chevallier, J.M.; Ducloux, H.; Elian, N.; Altman, J.J. Vitamin D deficiency before bariatric surgery: Should supplement intake be routinely prescribed? Obes. Surg. 2011, 21, 556-560.
84. Pittas, A.G.; Lau, J.; Hu, F.B.; Dawson-Hughes, B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2007, 92, 2017-2029.
85. De Boer, I.H.; Tinker, L.F.; Connelly, S.; Curb, J.D.; Howard, B.V.; Kestenbaum, B.; Larson, J.C.; Manson, J.E.; Margolis, K.L.; Siscovick, D. S. et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008, 31, 701-707.
86. Aloia, J.F. African Americans, 25-hydroxyvitamin D, and osteoporosis: A paradox. Am. J. Clin. Nutr. 2008, 88, 545-550.
87. Devaraj, S.; Jialal, G.; Cook, T.; Siegel, D.; Jialal, I. Low vitamin D levels in Northern American adults with the metabolic syndrome. Horm. Metab. Res. 2011, 43, 72-74.
88. Elsammak, M.Y.; Al-Wosaibi, A.A.; Al-Howeish, A.; Alsaeed, J. Vitamin D deficiency in Saudi Arabs. Horm. Metab. 2010, 42, 364-368.
89. Binkley, N.; Novotny, R.; Krueger, D.; Kawahara, T.; Daida, Y.G.; Lensmeyer, G.; Hollis, B.W.; Drezner, M.K. Low vitamin D status despite abundant sun exposure. J. Clin. Endocrinol. Metab. 2007, 92, 2130-2135.
90. Snijder, M.B.; van Dam, R.M.; Visser, M.; Deeg, D.J.; Dekker, J.M.; Bouter, L.M.; Seidell, J.C.; Lips, P. Adiposity in relation to vitamin D status and parathyroid hormone levels: A population-based study in older men and women. J. Clin. Endocrinol. Metab. 2005, 90, 4119-4123.
91. Shankar, A.; Sabanayagam, C.; Kalidindi, S. Serum 25-hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabetes Care 2011, 34, 1114-1119.
92. Pittas, A.G.; Chung, M.; Trikalinos, T.; Mitri, J.; Brendel, M.; Patel, K.; Lichtenstein, A.H.; Lau, J.; Balk, E.M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010, 152, 307-314.
93. Jorde, R.; Sneve, M.; Emaus, N.; Figenschau, Y.; Grimnes, G. Cross-sectional and longitudinal relation betweenserum 25-hydroxyvitamin D and body mass index: The Tromso study. Eur. J. Nutr. 2010, 49, 401-407.
94. Lagunova, Z.; Porojnicu, A.C.; Lindberg, F.A.; Aksnes, L.; Moan, J. Vitamin D status in Norwegian children and adolescents with excess body weight. Pediatr. Diabetes 2011, 12, 120-126.
95. Nunlee-Bland, G.; Gambhir, K.; Abrams, C.; Abdul, M.; Vahedi, M.; Odonkor, W. Vitamin D deficiency and insulin resistance in obese African-American adolescents. J. Pediatr. Endocrinol. Metab. 2011, 24, 29-33.
96. Rajakumar, K. de las Heras, J. Chen, T.C. Lee, S. Holick, M. F. Arslanian, S. A. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J. Clin. Endocrinol. Metab. 2011, 96, 1560-1567.
97. Muscogiuri, G.; Sorice, G.P.; Prioletta, A.; Pollicola, C.; della Casa, S.; Pontecorvi, A.; Giaccari, A. 25-hydroxyvitamin D concentration correlates with insulin sensitivity and BMI in obesity. Obesity 2010, 18, 1906-1910.
98. Gulseth, H.L.; Gjelstad, I.M.; Tierney, A.C.; Lovegrove, J.A.; Defoort, C.; Blaak, E.E.; Lopez-Miranda, J.; Kiec-Wilk, B.; Risérus, U.; Roche, H.M. et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010, 33, 923-925.
99. Del Gobbo, L.C.; Song, Y.; Dannenbaum, D.A.; Dewailly, E.; Egeland, G.M. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J. Nutr. 2011, 141, 290-295.
100. Chacko, S.A.; Song, Y.; Manson, J.E.; van Horn, L.; Eaton, C.; Martin, L.W.; McTiernan, A.; Curb, J.D.; Wylie-Rosett, J.; Phillips, L. S. et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am. J. Clin. Nutr. 2011, 94, 209-217.
101. Rosenblum, J.L.; Castro, V.M.; Moore, C.E.; Kaplan, L.M. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am. J. Clin. Nutr. 2012, 95, 101-108.
102. Forsythe, L.K.; Livingstone, M.B.; Barnes, M.S.; Horigan, G.; McSorley, E.M.; Bonham, M.P.; Magee, P.J.; Hill, T.R.; Lucey, A.J.; Cashman, K. D. et al. Effect of adiposity on vitamin D status and the 25-hydroxycholecalciferol response to supplementation in healthy young and older Irish adults. Br. J. Nutr. 2012, 107, 126-134.
103. Zhou, J.; Zhao, L.J.; Watson, P.; Zhang, Q.; Lappe, J.M. The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr. Metab. 2010, 23, 7-62.
104. Major, G.C.; Alarie, F.; Doré, J.; Phouttama, S.; Tremblay, A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am. J. Clin. Nutr. 2007, 85, 54-59.
105. Zittermann, A.; Frisch, S.; Berthold, H.K.; Götting, C.; Kuhn, J.; Kleesiek, K.; Stehle, P.; Koertke, H.; Koerfer, R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr. 2009, 89, 1321-1327.
106. Nagpal, J.; Pande, J.N.; Bhartia, A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabetes Med. 2009, 26, 19-27.
107. Sneve, M.; Figenschau, Y.; Jorde, R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur. J. Endocrinol. 2008, 159, 675-684.